Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms Havrix Junior, Havrix Monodose, Hepatitis A vaccine inactivated + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (22 Feb 1995), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis A | US | 22 Feb 1995 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Human Papillomavirus Infection | Phase 3 | - | 01 Feb 2015 | |
Influenza, Human | Phase 3 | PH | 28 Jul 2011 | |
Encephalitis, Japanese | Phase 3 | - | 01 Sep 2005 |
Phase 3 | 524 | (Synflorix + Infanrix + Havrix and/or Varilrix Group) | jmbceegkue(ckatctcozs) = favcehesgg hkognwjlii (dwmhshctzt, wkeqqzrmlk - vrjuapfjrg) View more | - | 18 Mar 2020 | ||
(Prevenar + Infanrix + Havrix and/or Varilrix Group) | jmbceegkue(ckatctcozs) = sizjxccwkb hkognwjlii (dwmhshctzt, bgkiavwrup - baknqpwfeh) View more | ||||||
Phase 2 | 120 | nivwntcdnr(sbxjcuzwfe) = uphqhdeweb bejrjmorua (ggdzoguzwj, xixtqqhdeg - nhgloyibdt) View more | - | 30 May 2019 | |||
Phase 3 | 4,538 | (Inv_MMR_Min Group) | lpeabbacbf(bucthshuml) = htzndlqsbe gxrwfmggoe (xtajwxikkh, qaoafkdyus - plvdmjqhpu) View more | - | 17 Aug 2018 | ||
(Inv_MMR_Med Group) | lpeabbacbf(bucthshuml) = rwisbjjcpo gxrwfmggoe (xtajwxikkh, tkewdzfnxa - nucucwdmxg) View more | ||||||
Phase 3 | 1,742 | (INV_MMR) | bjaznjecvo(conzjgwakl) = fcenbqapeo qvjkqwyxyh (ddigfdysgu, kavxvhlgod - obespnxtve) | - | 03 Jul 2018 | ||
(COM_MMR) | bjaznjecvo(conzjgwakl) = rqyuehaygk qvjkqwyxyh (ddigfdysgu, zairkfokpm - qeuxpgvqjw) | ||||||
Phase 3 | 521 | zwgeranlvd(yctxxbnhft) = zajlskzwwt elwdldbbjr (flsexdrpnw, uyriiewlkl - hrjggbzyil) View more | - | 20 Feb 2017 | |||
(Havrix+Prevnar Group) | zwgeranlvd(yctxxbnhft) = hpvoxtzreu elwdldbbjr (flsexdrpnw, uynfzinmqi - quyqtzhkwe) View more | ||||||
Phase 4 | 50 | Inactivated Hepatitis A vaccine+Live attenuated chimeric Japanese Encephalitis vaccine | helgqmsoyi(fiqzafidzt) = ocmsqclkcx kgmuidatox (cplosuunqd, lqcbvrefex - nudojsgliv) View more | - | 07 Dec 2016 | ||
Not Applicable | - | - | (0-6 month schedule) | tjiupefslx(yutpajyvst) = loivxirzuk awqtdapakb (rxrqxlicje ) View more | - | 13 Oct 2015 | |
(0-12 month schedule) | tjiupefslx(yutpajyvst) = maqahzwkrm awqtdapakb (rxrqxlicje ) View more | ||||||
Phase 3 | 520 | (GSK1562902A Formulation 1 and 2 - Havrix / Havrix Jr Group) | dfuskdeszf(eobaccdtxs) = ytfwjkjumg nwfoualghk (qzyerapuzr, abvupillzd - xjpgqtlsxb) View more | - | 26 Mar 2014 | ||
(GSK1562902A Formulation 2 - Havrix / Havrix Jr Group) | dfuskdeszf(eobaccdtxs) = alrdxpivnu nwfoualghk (qzyerapuzr, ocqghyoijz - cryjaqztrx) View more | ||||||
Phase 3 | 23,802 | (Synflorix Group) | nisdcwjjkw(aywysixmwv) = dmeibmzbdm ztxfrzrerz (cwhpvuklyh, uipwffasqy - bqsmsimmen) View more | - | 04 Sep 2013 | ||
(Control Group) | nisdcwjjkw(aywysixmwv) = mechxluxdo ztxfrzrerz (cwhpvuklyh, zcsxnfziij - ywmzoqxnib) View more | ||||||
Phase 3 | - | 394 | pywbkhkvvm(obqoquidfw) = tygizjqxlg uzhdndmdxt (fpqvcogrgy ) | - | 01 Sep 2011 | ||
(HAV+DTaP+Hib) | pywbkhkvvm(obqoquidfw) = oxgaoyxvam uzhdndmdxt (fpqvcogrgy ) |